BPC-157 + TB-500 — Repair · Regenerative Medicine

iThe essentials in 10 seconds

Combination of two complementary repair peptides: BPC-157 + TB-500
Act on tendons, muscles, joints and the intestinal mucosa
Subcutaneous injection (or near the area) — 4- to 6-week course
The reference duo to accelerate healing and recovery

IWhat is BPC-157 + TB-500?

BPC-157 + TB-500The repair duo

BPC-157 (Body Protective Compound) is a protective gastric protein fragment: it accelerates the healing of tendons, muscles and the intestinal wall, and calms inflammation. TB-500 (Thymosin β4 fragment) promotes the migration of repair cells and tissue flexibility. Together, they cover local and systemic repair.

Peptides widely used in sports medicine but off-label: use reserved for a supervised medical setting, in the absence of contraindications (progressive cancer).

An innovative approach, an experimental use

The molecules presented on this site are innovative and fall under experimental use. Human data remain limited: a studied mechanism or a preclinical observation is not sufficient to demonstrate a benefit. The regulatory status in Morocco is not established for most of these peptides. Any use is decided within the framework of a medical consultation, with follow-up — never alone, never without an assessment.

IIThe benefits

◆Tendons & ligamentsTargeted repair

Accelerates the healing of tendons and ligaments (tendinopathies, sprains) and reduces pain.

◆MuscleMuscle recovery

Supports the repair of exertion-induced micro-lesions and reduces soreness and stiffness.

◆IntestineThe digestive protector

BPC-157 protects and repairs the intestinal mucosa (ulcers, inflammation, permeability).

◆InflammationThe local soother

Reduces inflammation at the injury site — useful in chronic joint pain.

◆RecoveryFaster return

Shortens recovery time after injury or after intense exertion.

◆Tissue flexibilityThe role of TB-500

Improves elasticity and local circulation, complementing BPC-157.

IIIRecommendations & how to use

How to useDosage · route · storage

Reconstitution: each vial reconstituted with bacteriostatic water (dilution provided during consultation)

Route: subcutaneous injection — general (abdomen) and/or near the injured area · Frequency: regular injections over the day or week depending on the form · Storage: refrigerated (2–8 °C).
The duo does not replace immobilization/rehabilitation when indicated.

Prices on request

Dosage	Price
5 + 5 mg	Provided on request
10 + 10 mg	Provided on request

Prices are not published online: they are provided on request, during a consultation or by telephone.

Supplied as a vial with bacteriostatic water and syringes — reconstituted during the consultation.

IVThe protocols

◆Repair protocolInjury · tendon · inflammation

Objective: accelerate the healing of an injury (tendon, muscle, joint) and calm inflammation.

Dose: BPC-157 + TB-500 depending on the form, over 4 to 6 weeks

Frequency: regular injections (several times/week), adjusted to pain

Reassessment at the end of the course

Monitoring: progression of pain and mobility; combine rehabilitation and rest.

◆Sports protocolRecovery · prevention

Objective: reduce recovery times and protect tendons and muscles in athletes.

4-week course targeting periods of intense training or competition

Regular injections, adjusted to training volume

Break between courses

Combine: hydration, protein, sleep and load management.

◆GLOW / KLOW protocolReady-to-use blends (with GHK-Cu, ± KPV)

Objective: the same repair logic in a single vial — GLOW = GHK-Cu + BPC-157 + TB-500 (70 mg) · KLOW = GLOW + anti-inflammatory KPV (80 mg).

GLOW: 3 ml bacteriostatic water = 23.3 mg/ml · 10 units (0.10 ml)/day ≈ 2.3 mg (GHK-Cu 1.7 mg + BPC-157 0.33 mg + TB-500 0.33 mg)

KLOW: 3 ml = 26.7 mg/ml · titration: weeks 1–2 = 7.5 units, weeks 3–4 = 15 units, weeks 5–8 = 22.5 units

Frequency: 1 subcutaneous injection/day, 4 to 6 weeks then a break (break required due to copper load)

The blend is rich in GHK-Cu: for an injury, supplement with separate TB-500 (2 mg ×2/week). No clinical trial has evaluated these combinations.

VProtocol rules

Good habits

Continue rehabilitation and rest when indicated
Adequate hydration and protein intake
Quality sleep: the engine of repair
Note pain and mobility for monitoring
Store vials in the refrigerator

To avoid / precautions

No self-injection without medical training
Do not force exertion on an area being repaired
Do not chain courses without a break
Never mix peptides in the same vial
Progressive cancer: contraindication — medical advice mandatory

VIYour journey in 3 steps

Step 1 · Consultation

Assessment & training

Evaluation of the injury, contraindications, injection training, protocol provided.

Step 2 · 4–6 wk course

Injections & monitoring

Regular injections, monitoring of pain and mobility, associated rehabilitation.

Step 3 · End of course

Reassessment

Recovery assessment, decision on next steps (break, new course if needed).

VIISide effects & level of evidence

Level of evidencePreclinicalPreclinical data (in vitro / animal); no published controlled trial in humans.

Reported adverse effects

Injection-site pain or redness
Dizziness, light-headedness
Nausea
Fatigue, headache

Contraindications & precautions

Active cancer or cancer history (angiogenesis)
Pregnancy, breastfeeding
Children and adolescents
Uncontrolled autoimmune disease: caution

Non-exhaustive list based on the available literature and known class effects; it replaces neither a product label nor an individual medical assessment.

VIIIPublications & references

230 publications indexed in PubMed · of which 55 with human subjects

Search on PubMed Clinical trials (ClinicalTrials.gov)

Documentary references: the existence of a publication establishes neither efficacy nor safety for personal use. The regulatory status in Morocco must be verified.